Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Int J Med Sci 2021; 18(1):169-175. doi:10.7150/ijms.49906 This issue Cite

Research Paper

The expression and clinical significance of TPM4 in hepatocellular carcinoma

Linjing Li1✉*, Tao Ye2*, Qingyan Zhang3*, Xin Li2, Li Ma1, Jing Yan1

1. Department of Clinical Laboratory Center, The Second Hospital of Lanzhou University, Lanzhou 730000, P.R. China.
2. The First School of Clinical Medicine, Southern Medical University, Guangzhou, China, 510515.
3. Center of Reproductive Medicine, Department of Obstetrics and Gynecology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, 510080.
*These authors contributed equally to this article.

✉ Corresponding author: Linjing Li, Department of Clinical Laboratory Center, The Second Hospital of Lanzhou University, 82 Cuiying Gate Road, Lanzhou, Gansu, 730000, P.R. China. E-mail: lilinjedu.cn.

Citation:
Li L, Ye T, Zhang Q, Li X, Ma L, Yan J. The expression and clinical significance of TPM4 in hepatocellular carcinoma. Int J Med Sci 2021; 18(1):169-175. doi:10.7150/ijms.49906. https://www.medsci.org/v18p0169.htm
Other styles

File import instruction

Abstract

Hepatocellular carcinoma (HCC) is known as the fifth most common cancer in the world for its poor prognosis. New diagnostic markers and treatments are urgent to discover. To evaluate the protein expression of Tropomyosin4 (TPM4) and investigate its prognostic value in HCC, we collected 110 patients with different degrees of HCC and 10 patients with normal hepatic tissues and performed immunohistochemistry. Western bot was used to evaluate the expression of TPM4 in three HCC cell lines (HepG2, Huh7, SMMC-7721) and normal liver cell line LO2, as well as 7 HCC tissues and 7 normal hepatic tissues. The results of TPM4 staining revealed that TPM4 expression in HCC was higher than that in normal hepatic tissues, which was positive in 51.8% (n=57) and negative in 48.2% (n=53) while in normal hepatic tissues positive staining was in 10% (n=1) and negative staining was in 90% (n=9) (P=0.011). And the expression of TPM4 was related to pT status, grade and stage (P<0.001, P=0.015 and P<0.001, respectively). Western blot results indicated that TPM4 was high expressed in HCC cell line and HCC tissues. In conclusion, we believe that TPM4 can be applied as a diagnostic and prognostic marker to assist the management of HCC.

Keywords: hepatocellular carcinoma, TPM4, biological marker, clinicopathological parameters, diagnosis

Citation styles

APA
Li, L., Ye, T., Zhang, Q., Li, X., Ma, L., Yan, J. (2021). The expression and clinical significance of TPM4 in hepatocellular carcinoma. International Journal of Medical Sciences, 18(1), 169-175. https://doi.org/10.7150/ijms.49906.

ACS
Li, L.; Ye, T.; Zhang, Q.; Li, X.; Ma, L.; Yan, J. The expression and clinical significance of TPM4 in hepatocellular carcinoma. Int. J. Med. Sci. 2021, 18 (1), 169-175. DOI: 10.7150/ijms.49906.

NLM
Li L, Ye T, Zhang Q, Li X, Ma L, Yan J. The expression and clinical significance of TPM4 in hepatocellular carcinoma. Int J Med Sci 2021; 18(1):169-175. doi:10.7150/ijms.49906. https://www.medsci.org/v18p0169.htm

CSE
Li L, Ye T, Zhang Q, Li X, Ma L, Yan J. 2021. The expression and clinical significance of TPM4 in hepatocellular carcinoma. Int J Med Sci. 18(1):169-175.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use